Acadia Hits Home Run in Phase 3 Trial and Brings Market Focus to Parkinson's

Published December 5, 2012

Acadia Hits Home Run In Phase 3 Trial And Brings Market Focus To Parkinson's

Filed under: drug treatment news articles

I have no business relationship with any company whose stock is mentioned in this article. (More…) Last Tuesday, Acadia Pharma … Once you have those trial results, assuming they're positive, it sure seems like you have demonstrated efficacy and the …
Read more on Seeking Alpha

What's Driving This Biotech Stock Through the Roof?

Filed under: drug treatment news articles

By Brenton Flynn and Max Macaluso, Ph.D. | More Articles December 4, 2012 | Comments (0) … Investors are awaiting news on several indications for treatment of various types of cancer from the company's drug Bavituximab. The company faced controversy …
Read more on Motley Fool